About TTI, Inc.
TTI, Inc. is a Healthcare company based in Paris (France) founded in 2017, and was acquired by Inframark in June 2023. Post-treatment management platforms for cancer patients are provided. It operates on a AI-as-a-Service, Subscription Services, and HealthTech model. TTI, Inc. has raised $6.08 million across 2 funding rounds from investors including Inframark. TTI, Inc. offers products and services including Wave Health App, Wave Connect Portal, and Enterprise Solutions. Its focus areas include Digital Health and Patient Engagement Solutions.
Company details
Healthcare transformation is facilitated by TTI, Inc. through digital health insights and real-world data. Patient-centric solutions are offered via the Wave Health platform, including ePRO tools, HCP portals, and AI-driven analytics. Diverse data sets are collected to supplement clinical information with individual context, generating personalized insights. Sectors such as oncology and chronic illness management are targeted, empowering patients, providers, payors, and life sciences with tools to improve outcomes, reduce costs, and optimize treatments.
Products & Services of TTI, Inc.
TTI, Inc. offers a comprehensive portfolio of products and services, including Wave Health App, Wave Connect Portal, and Enterprise Solutions.
Personalized health insights are provided using AI technology.
Real-time patient data is managed for care workflows.
Patient risk reduction tools are offered for optimization.
Funding Insights of TTI, Inc.
TTI, Inc. has successfully raised a total of $6.08M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.5 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.08M
- Total Rounds 2
- Last Round Series A — $4.5M
- First Round $1.58M
(Dec 2017)
All 2 funding rounds of TTI, Inc. with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $4.5M | Series A | – | – | – |
| Dec 2017 | $1.58M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in TTI, Inc.
TTI, Inc. has secured backing from 1 investor. Prominent investors backing the company include Inframark.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Water treatment services and infrastructure operations are provided. | 1978 | inframark.com | Katy, United States |
Investor details for TTI, Inc.
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TTI, Inc.
2 people are tracked at TTI, Inc. (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Matt Lashey | CEO; Creator of chemoWave | Leadership |
Amrit Khatiwada | Android Software Engineer, Mobile Lead | Team |
Complete people profiles for TTI, Inc.
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TTI, Inc.
4 dated milestones of TTI, Inc. across 7 years, from founding to its latest funding, stage changes and deals.
- Founded TTI, Inc. is founded.
- Funding First funding round of $1.6M.
- Exit Acquired by Inframark.
- Funding Latest funding round, Series A, of $4.5M.
Web traffic of TTI, Inc.
The website of TTI, Inc. (tti.care) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 9.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tti, Inc.
Complete news archive for TTI, Inc.
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TTI, Inc.
TTI, Inc. was founded in 2017.
TTI, Inc. is headquartered in Paris, France.
TTI, Inc. is a funded company, having raised a total of $6.08M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.58M, raised on Dec 2017.
Healthcare transformation is facilitated by TTI, Inc. through digital health insights and real-world data. Patient-centric solutions are offered via the Wave Health platform, including ePRO tools, HCP portals, and AI-driven analytics. Diverse data sets are collected to supplement clinical information with individual context, generating personalized insights. Sectors such as oncology and chronic illness management are targeted, empowering patients, providers, payors, and life sciences with tools to improve outcomes, reduce costs, and optimize treatments.
TTI, Inc. offers Wave Health App, Wave Connect Portal, and Enterprise Solutions.
TTI, Inc. has 1 investor. Key investors include Inframark.
TTI, Inc. operates through Tti, Inc..
Yes. TTI, Inc. was acquired by Inframark in June 2023.